{
    "Trade/Device Name(s)": [
        "ETEST Eravacycline (ERV)",
        "ETEST ERV",
        "ETEST\u00ae Eravacycline"
    ],
    "Submitter Information": "bioMerieux SA",
    "510(k) Number": "K192050",
    "Predicate Device Reference 510(k) Number(s)": [
        "K180936"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JWY"
    ],
    "Summary Letter Date": "July 30, 2019",
    "Summary Letter Received Date": "July 31, 2019",
    "Submission Date": "July 30, 2019",
    "Regulation Number(s)": [
        "21 CFR 866.1640"
    ],
    "Regulation Name(s)": [
        "Antimicrobial Susceptibility Test Powder"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Eravacycline"
    ],
    "Specimen Type(s)": [
        "Non-fastidious Gram-negative bacteria",
        "Gram-positive aerobic bacteria",
        "Fastidious bacteria"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "ETEST\u00ae strip",
        "Agar media"
    ],
    "Method(s)/Technology(ies)": [
        "Manual quantitative technique",
        "Antibiotic gradient",
        "Minimum Inhibitory Concentration (MIC) determination"
    ],
    "Methodologies": [
        "Antimicrobial susceptibility testing",
        "MIC reading"
    ],
    "Submission Type(s)": [
        "Reagent",
        "Strip",
        "Antimicrobial susceptibility test system"
    ],
    "Document Summary": "FDA 510(k) summary for ETEST Eravacycline (ERV), a manual strip-based system for determining MIC of eravacycline against aerobic Gram-negative and Gram-positive bacteria.",
    "Indications for Use Summary": "Determination of antimicrobial susceptibility of non-fastidious Gram-negative and Gram-positive aerobic bacteria and fastidious bacteria to Eravacycline using a manual strip-based MIC technique.",
    "fda_folder": "Microbiology"
}